Evidence map›Paper›PMID 29794226›Full record

ReviewJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

The Immunoimaging Toolbox.

Aaron T Mayer, Sanjiv S Gambhir

Abstract readReview
In one paragraph

Review in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Labeling of Bruton's Tyrosine Kinase (BTK) Inhibitor [International journal of molecular sciences · 2024
    Article
  8. Article
  9. Theranostic Fluorescent Probes.Chemical reviews · 2024
    Review
  10. Acta pharmacologica Sinica · 2024
    Article
  11. Article
  12. Article
  13. Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Review
  14. Article
  15. Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  16. Immuno-Imaging (PET/SPECT)-Quo Vadis?Molecules (Basel, Switzerland) · 2022
    Review
  17. Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aaron T MayerDepartment of Bioengineering, Stanford University, Stanford, California; and.
Sanjiv S GambhirDepartment of Bioengineering, Stanford University, Stanford, California; and sgambhir@stanford.edu.

Funding

Predoctoral Training in Biomedical Imaging at Stanford UniversityT32EB009653 · NIBIB · STANFORD UNIVERSITY · PI BUTTS-PAULY, KIM · 2010 to 2019
$2.1M
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host DiseaseR01CA201719 · NCI · STANFORD UNIVERSITY · PI JAMES, MICHELLE LOUISE · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA201719NIBIB NIH HHS T32 EB009653
6 · The paper itself

Abstract

The recent clinical success of cancer immunotherapy has renewed interest in the development of tools to image the immune system. In general, immunotherapies attempt to enable the body's own immune cells to seek out and destroy malignant disease. Molecular imaging of the cells and molecules that regulate immunity could provide unique insight into the mechanisms of action, and failure, of immunotherapies. In this article, we will provide a comprehensive overview of the current state-of-the-art immunoimaging toolbox with a focus on imaging strategies and their applications toward immunotherapy.

Indexed as

AnimalsHumansImmunityImmunotherapyMolecular ImagingNeoplasmscell trackingimmune imagingimmunotherapymolecular imagingoncologyradioimmunoimaging

Identifiers

PMID29794226
PMCPMC6071502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.